Highlander Capital Management, LLC Bio N Tech Se Call Options Transaction History
Highlander Capital Management, LLC
- $245 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BNTX
# of Institutions
341Shares Held
40MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$798 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$417 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$396 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$185 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$177 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $23.7B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...